Evidence map›Paper›PMID 37350897›Full record

ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2023

Interpretable Stratification for Chronic Kidney Disease Progression Based on Time to Event Analysis.

Mohamed Ghalwash, Akira Koseki, Toshiya Iwamori, Michiharu Kudo, Pablo Meyer

Open access · greenAbstract read
In one paragraph

Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mohamed GhalwashIBM Research, Healthcare and Life Sciences, Yorktown, NY, USA.
Akira KosekiIBM Research, Healthcare and Life Sciences, Tokyo, Japan.
Toshiya IwamoriIBM Research, Healthcare and Life Sciences, Tokyo, Japan.
Michiharu KudoIBM Research, Healthcare and Life Sciences, Tokyo, Japan.
Pablo MeyerIBM Research, Healthcare and Life Sciences, Yorktown, NY, USA.
IBM Research - Tokyo · JPIBM (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Chronic Kidney Disease (CKD), kidneys are damaged and lose their ability to filter blood, leading to a plethora of health consequences that end up in dialysis. Despite its prevalence, CKD goes often undetected at early stages. In order to better understand disease progression, we stratified patients with CKD by considering the time to dialysis from diagnosis of early CKD (stages 1 or 2). To achieve this, we first reduced the number of clinical features in a predictive time-to-dialysis model and identified the top important features on a cohort of ∼ 40, 000 CKD patients. The extracted features were used to stratify a subpopulation of 3

Identifiers

PMID37350897
PMCPMC10283089
OpenAlexW4381715565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.